Gujarat Kidney And Super Speciality Share Price
193.62+3.28 (+1.72%)
+85.21% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
ASTERDMNSE
FORTISNSE
MEDANTANSE
NHNSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
GKSLNSE
Gujarat Kidney And Super Speciality Share Price
193.62+3.28 (+1.72%)
+85.21% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 104% |
| - | - | - | 77% |
| - | - | - | - |
| 54% | 54% | 81% | 12% |
Peer Comparison
Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
ASTERDM
FORTIS
MEDANTA
NH
LALPATHLAB
KIMS
AGARWALEYE
GKSL
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 7,885 | ₹115172 Cr | 55.12 | 40.39 | 207.67 | ₹1942 Cr |
| 900.2 | ₹89214 Cr | 61.23 | 3.31 | 19.84 | ₹1442 Cr |
| 685.2 | ₹87775 Cr | 98.37 | 1.96 | 11.95 | ₹892 Cr |
| 683.65 | ₹60233 Cr | 189.01 | 0.31 | 6.76 | ₹388 Cr |
| 760.45 | ₹57754 Cr | 55.11 | 3.53 | 20.1 | ₹1042 Cr |
| 1,303 | ₹35806 Cr | 64.38 | 5.91 | 29.85 | ₹556 Cr |
| 1,729.6 | ₹35189 Cr | 43.12 | 10.14 | 65.36 | ₹806 Cr |
| 1,975.8 | ₹33078 Cr | 61.04 | 10.11 | 42.51 | ₹505 Cr |
| 692.35 | ₹29482 Cr | 144.31 | 1.04 | 12.74 | ₹241 Cr |
| 478.9 | ₹15339 Cr | 103.39 | 1.43 | 13.88 | ₹133 Cr |
| 192.1 | ₹1497 Cr | 94.55 | 0.66 | 2.66 | ₹15 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|
| ₹34 Cr | ₹31 Cr | ₹23 Cr | ₹13 Cr | ₹15 Cr | ₹10 Cr | ₹12 Cr | ₹9 Cr |
| ₹69 L | ₹71 L | ₹6 L | ₹9 L | ₹80,000 | ₹5 L | ₹5 L | ₹5 L |
| ₹35 Cr | ₹31 Cr | ₹23 Cr | ₹13 Cr | ₹15 Cr | ₹10 Cr | ₹12 Cr | ₹9 Cr |
| ₹27 Cr | ₹26 Cr | ₹18 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹5 Cr |
| ₹9 Cr | ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹9 Cr | ₹3 Cr | ₹5 Cr | ₹5 Cr |
| ₹66 L | ₹82 L | ₹60 L | ₹28 L | ₹18 L | ₹16 L | ₹17 L | ₹16 L |
| ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹7 Cr | ₹2 Cr | ₹4 Cr | ₹4 Cr |
| ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹5 Cr | ₹1 Cr | ₹3 Cr | ₹3 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| — | — | — | — | — |
| ₹16 Cr | ₹11 Cr | ₹20 L | ₹20 L | ₹20 L |
| ₹0 | ₹0 | ₹9 Cr | ₹0 | ₹0 |
| ₹237 Cr | ₹15 Cr | ₹2 Cr | ₹17 L | ₹18 L |
| ₹237 Cr | ₹15 Cr | ₹2 Cr | ₹17 L | ₹18 L |
| ₹253 Cr | ₹26 Cr | ₹11 Cr | ₹37 L | ₹38 L |
| ₹2 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 |
| ₹77 L | ₹2 Cr | ₹2 Cr | ₹0 | ₹0 |
| ₹1 Cr | ₹50 L | ₹0 | ₹0 | ₹0 |
| -₹3 Cr | -₹68 L | -₹3 L | -₹4 L | -₹4 L |
| ₹13 Cr | ₹4 Cr | ₹4 Cr | ₹0 | ₹0 |
| ₹77 L | ₹45 L | ₹26 L | ₹0 | ₹0 |
| ₹13 Cr | ₹6 Cr | ₹5 Cr | -₹4 L | -₹4 L |
| — | — | — | — | — |
| ₹8 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr |
| ₹6 Cr | ₹16 Cr | ₹2 Cr | ₹3 L | ₹3 L |
| ₹13 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 |
| ₹19 L | ₹2 Cr | ₹39 L | ₹0 | ₹48,000 |
| ₹28 Cr | ₹22 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr |
| ₹295 Cr | ₹55 Cr | ₹20 Cr | ₹4 Cr | ₹4 Cr |
| ₹0 | ₹3 L | ₹0 | ₹0 | ₹0 |
| ₹16 Cr | ₹4 Cr | ₹2 Cr | ₹0 | ₹0 |
| — | — | — | — | — |
| ₹152 Cr | ₹37 Cr | ₹14 Cr | ₹0 | ₹3 Cr |
| ₹23 Cr | ₹6 Cr | ₹32 L | ₹0 | ₹57 L |
| ₹129 Cr | ₹31 Cr | ₹14 Cr | ₹0 | ₹3 Cr |
| ₹12 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹12 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹48 Cr | ₹13 L | ₹6 L | ₹0 | ₹0 |
| ₹2 Cr | ₹2 Cr | ₹7 L | ₹3 Cr | ₹0 |
| ₹191 Cr | ₹33 Cr | ₹14 Cr | ₹3 Cr | ₹3 Cr |
| — | — | — | — | — |
| ₹2 Cr | ₹68 L | ₹27 L | ₹0 | ₹0 |
| ₹39 Cr | ₹15 Cr | ₹4 Cr | ₹1 Cr | ₹1 Cr |
| ₹56 Cr | ₹3 Cr | ₹1 Cr | ₹35,000 | ₹34,000 |
| ₹77 L | ₹87 L | ₹90 L | ₹0 | ₹0 |
| ₹7 Cr | ₹2 Cr | ₹18 L | ₹0 | ₹0 |
| ₹105 Cr | ₹22 Cr | ₹7 Cr | ₹1 Cr | ₹1 Cr |
| ₹77 Cr | ₹15 L | ₹2 Cr | -₹2 Cr | -₹2 Cr |
| ₹295 Cr | ₹55 Cr | ₹20 Cr | ₹4 Cr | ₹4 Cr |
| ₹32 | ₹5 | ₹87 | ₹19 | ₹19 |
| ₹32 | ₹5 | ₹0 | ₹0 | ₹0 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| ₹21 Cr | ₹13 Cr | ₹2 Cr | -₹62,000 | ₹14 L |
| ₹6 Cr | ₹4 Cr | -₹23 L | ₹0 | ₹57 L |
| -₹22 Cr | -₹35 L | -₹65 L | ₹1 L | -₹61 L |
| ₹6 Cr | ₹16 Cr | ₹1 Cr | ₹50,000 | ₹10 L |
| -₹4 Cr | ₹14 Cr | ₹1 Cr | ₹1,000 | ₹22,000 |
| -₹214 Cr | -₹18 Cr | ₹22 L | ₹0 | ₹0 |
| ₹228 Cr | ₹6 Cr | -₹47 L | ₹0 | ₹0 |
| ₹11 Cr | ₹2 Cr | ₹97 L | ₹1,000 | ₹22,000 |
| ₹3 Cr | ₹97 L | ₹35,000 | ₹34,000 | ₹12,000 |
| ₹13 Cr | ₹3 Cr | ₹97 L | ₹35,000 | ₹34,000 |
Fundamental Ratios
Consolidated
Standalone

No results found
Gujarat Kidney And Super Speciality Share Price
193.62+3.28 (+1.72%)
+85.21% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 2 out of 9 oscillators
RSI
68.79Buy
STOCH %K
64.72Neutral
MACD Level(12,26)
8.02Buy
Ultimate Oscillator
48.99Sell
Aroon Oscillator
86.00Buy
BOP
0.29Buy
CCI
172.59Sell
Williams %R
-35.28Neutral
Momentum
20.02Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 7
Bearish signals: 0 out of 9 moving averages
EMA 9
184.32Buy
SMA 9
181.62Buy
EMA 21
177.08Buy
SMA 21
178.22Buy
EMA 50
163.27Buy
SMA 50
158.34Buy
EMA 200
0.00Neutral
SMA 200
0.00Neutral
WMA 20
180.84Buy
Pivot
Pivot
Classic
Resistance 5
254.71
Resistance 4
238.73
Resistance 3
222.75
Resistance 2
206.77
Resistance 1
198.55
Pivot
190.79
Support 1
182.57
Support 2
174.81
Support 3
158.83
Support 4
142.85
Support 5
126.87
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Gujarat Kidney And Super Speciality Share Price
193.62+3.28 (+1.72%)
+85.21% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| 71.45% | 71.45% | 71.45% | 71.45% |
| 4.89% | 4.89% | 10.47% | 13.09% |
| 0.56% | 0.56% | 1.67% | 2.85% |
| 0.00% | 0.00% | 0.00% | 0.00% |
| 23.10% | 23.10% | 16.41% | 12.61% |
Bulk & block deals
Name
Natvarsinh T Chavda
Qe Securities Llp
Natvarsinh T Chavda
Qe Securities Llp
Junomoneta Finsol Private Limited
Microcurves Trading Private Limited
Nk Securities Research Private Limited
Qe Securities Llp
J4s Financial Solutions Llp
Vinsul Makardi Ltd
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 05 Oct 2026 | Purchase | 13.64 Cr | ₹189.10 | 7.21 L | Bulk | 0.914939 | NSE |
| 05 Oct 2026 | Purchase | 8.54 Cr | ₹192.61 | 4.43 L | Bulk | 0.562308 | NSE |
| 05 Oct 2026 | Sell | 13.86 Cr | ₹192.11 | 7.21 L | Bulk | 0.914939 | NSE |
| 05 Oct 2026 | Sell | 8.13 Cr | ₹190.48 | 4.27 L | Bulk | 0.54166 | NSE |
| 01 Oct 2026 | Purchase | 29.89 Cr | ₹198.86 | 15.03 L | Bulk | 1.906598 | NSE |
| 01 Oct 2026 | Purchase | 29.95 Cr | ₹199.79 | 14.99 L | Bulk | 1.901206 | NSE |
| 01 Oct 2026 | Purchase | 20.60 Cr | ₹199.83 | 10.31 L | Bulk | 1.307579 | NSE |
| 01 Oct 2026 | Purchase | 18.58 Cr | ₹197.12 | 9.43 L | Bulk | 1.195677 | NSE |
| 01 Oct 2026 | Purchase | 16.98 Cr | ₹198.02 | 8.58 L | Bulk | 1.08777 | NSE |
| 01 Oct 2026 | Purchase | 16.19 Cr | ₹198.41 | 8.16 L | Bulk | 1.034684 | NSE |
Insider trading & SAST
Client name
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|
Gujarat Kidney And Super Speciality Share Price
193.62+3.28 (+1.72%)
+85.21% past 1 Year
Gujarat Kidney and Super Speciality operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary (which are surgical services) and tertiary care (which are
Corporate Actions
Date
Type
Details
Company details
Gujarat Kidney And Super Speciality Share Price
193.62+3.28 (+1.72%)
+85.21% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Gujarat Kidney And Super Speciality Share Price
193.62+3.28 (+1.72%)
+85.21% past 1 Year
News
Gujarat Kidney and Super Speciality inform about newspaper publication
Equity
GKSL
Guj. Kidney & Super reports Profit after tax of 1.37 Crores, in the March 2026 quarter
Equity
GKSL
Gujarat Kidney and Super Speciality rises on getting nod to incorporate wholly owned subsidiary
Equity
GKSL
Gujarat Kidney Q3 FY26 Results: Revenue Growth Accelerates Amid Margin Compression
Equity
GKSL
Guj. Kidney & Super reports Profit after tax of 2.33 Crores, in the December 2025 quarter
Equity
GKSL
GKSL Board Approves 51% Stake Acquisitions in Patel Pharmacy and Patel Hospital for Rs 12.50 Crores
Equity
GKSL
Gujarat Kidney And Super Speciality: Board Greenlights 49% Stake Purchase In Harmony Medicare
Equity
GKSL
Gujarat Kidney and Super Speciality informs about outcome of board meeting
Equity
GKSL
Gujarat Kidney and Super Speciality to acquire Parekhs Hospital
Equity
GKSL
Gujarat Kidney and Super Speciality Shares List at 6% Premium on BSE at Rs 120.75 vs Issue Price Rs 114.
Broader Market
GKSL
Guj. Kidney & Super reports Profit after tax of 2.30 Crores, in the September 2025 quarter
Equity
GKSL

